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Background
Beta-adrenergic blockers such as propranolol have been
commonly used for treatment of several cardiovascular
complications such as arterial hypertension and arrhyth-
mias. Anti-inflammatory effects of propranolol have also
been reported. Interleukin-13 (IL-13) (a Th2-type cytokine)
is a mediator of airway inflammation and increases in
immediate-type allergy. In this study the effect of propra-
nolol on IL-13 secretion in human peripheral blood mono-
nuclear cells (hPBMCs) have been investigated in vitro.
Methods
HPBMCs were used in this study. The cells were cultured
in complete RPMI medium and then incubated with dif-
ferent concentrations of propranolol (4 ×10-7 - 4 ×10-4 M)
for 24 hours. The level of IL-13 secreted in the cell culture
supernatants was measured with the enzyme-linked
immunosorbent assay (ELISA) kits (R&D systems).
Results
Propranolol significantly and dose-dependently reduced
IL-13 production in hPBMCs, compared to untreated
control cells.
Conclusions
According to the results of this study, propranolol con-
siderably decreased the IL-13 expression in hPBMCs.
Propranolol with its inhibitory effect on IL-13 production
may be useful in alleviating the IL-13- induced respira-
tory inflammation in related diseases such as chronic
obstructive pulmonary disease (COPD) and asthma.
Therefore propranolol along with its chronic long-term
usage in cardiac problems, might have potential implica-
tion in inflammatory disorders.
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